Nanoengineered drug-releasing Ti wires as an alternative for local delivery of chemotherapeutics in the brain

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 2069-2076

  Gulati, Karan ^a,b   Aw, Moom Sinn ^a   Losic, Dusan ^a,b  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Brain implants; Dopamine; Doxorubicin; Local drug delivery; Titania nanotubes

Indexed keywords

DOPAMINE; DOXORUBICIN; NANOTUBE; NANOWIRE; TITANIUM WIRE; UNCLASSIFIED DRUG; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ANTINEOPLASTIC AGENT; METAL NANOPARTICLE; TITANIUM; TITANIUM DIOXIDE;

ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STRUCTURE; IN VITRO STUDY; NANOENGINEERING; NANOFABRICATION; SCANNING ELECTRON MICROSCOPY; THERMOGRAVIMETRY; ULTRAVIOLET SPECTROSCOPY; ANIMAL; BRAIN; CHEMISTRY; DRUG EFFECT; DRUG IMPLANT; METABOLISM; NANOMEDICINE; NANOTECHNOLOGY; ULTRASTRUCTURE;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD-BRAIN BARRIER; BRAIN; DOPAMINE; DOXORUBICIN; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, SCANNING; NANOMEDICINE; NANOTECHNOLOGY; NANOTUBES; NANOWIRES; NEUROTRANSMITTER AGENTS; TITANIUM;

EID: 84864596515     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S29917     Document Type: Article

References (35)

1. Mainardes RM, Silva LP. Drug delivery systems: past, present, and future. Curr Drug Targets. 2004;5(5):449-455.
2. LaVan DA, McGuire T, Langer R. Small-scale systems for in vivo drug delivery. Nat Biotechnol. 2003;21(10):1184-1191.
3. Pardridge WM. Blood-brain barrier drug targeting: the future of brain drug development. Mol Interv. 2003;3(2):90-105, 51.
4. Wang PP, Frazier J, Brem H. Local drug delivery to the brain. Adv Drug Deliv Rev. 2002;54(7):987-1013.
5. Groothuis DR. The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery. Neuro Oncol. 2000;2(1): 45-59.
6. Baratchi S, Kanwar RK, Khoshmanesh K, et al. Promises of nanotechnology for drug delivery to brain in neurodegenerative diseases. Curr Nanosci. 2009;5(1):15-25.
7. Bodor N, Buchwald P. Recent advances in the brain targeting of neuropharmaceuticals by chemical delivery systems. Adv Drug Deliv Rev. 1999;36(2-3):229-254.
8. Lesniak MS, Brem H. Targeted therapy for brain tumours. Nat Rev Drug Discov. 2004;3(6):499-508.
9. Au JL, Jang SH, Wientjes MG. Clinical aspects of drug delivery to tumors. J Control Release. 2002;78(1-3):81-95.
10. Laquintana V, Trapani A, Denora N, Wang F, Gallo JM, Trapani G. New strategies to deliver anticancer drugs to brain tumors. Expert Opin Drug Deliv. 2009;6(10):1017-1032.
11. Gilert A, Machluf M. Nano to micro delivery systems: targeting angiogenesis in brain tumors. J Angiogenes Res. 2010;2(1):20.
12. Raghavan R, Brady ML, Rodríguez-Ponce MI, Hartlep A, Pedain C, Sampson JH. Convection-enhanced delivery of therapeutics for brain disease, and its optimization. Neurosurg Focus. 2006;20(4):E12.
13. Oh S, Odland R, Wilson SR, et al. Improved distribution of small molecules and viral vectors in the murine brain using a hollow fiber catheter. J Neurosurg. 2007;107(3):568-577.
14. Scott AW, Tyler BM, Masi BC, et al. Intracranial microcapsule drug delivery device for the treatment of an experimental gliosarcoma model. Biomaterials. Apr 2011;32(10):2532-2539.
15. Morrison PF, Chen MY, Chadwick RS, Lonser RR, Oldfield EH. Focal delivery during direct infusion to brain: role of flow rate, catheter diameter, and tissue mechanics. Am J Physiol. 1999;277(4 Pt 2):R1218-R1229.
16. Tyler B, Fowers KD, Li KW, et al. A thermal gel depot for local delivery of paclitaxel to treat experimental brain tumors in rats. J Neurosurg. 2010;113(2):210-217.
17. Brem H, Mahaley MS Jr, Vick NA, et al. Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J Neurosurg. 1991;74(3):441-446.
18. Weinberg BD, Blanco E, Gao J. Polymer implants for intratumoral drug delivery and cancer therapy. J Pharm Sci. 2008;97(5):1681-1702.
19. Lin SH, Kleinberg LR. Carmustine wafers: localized delivery of chemotherapeutic agents in CNS malignancies. Expert Rev Anticancer Ther. 2008;8(3):343-359.
20. 2 nanotubes and other self-aligned MO(x) structures. Chem Commun (Camb). 2009;28(20):2791-2808.
21. Popat KC, Eltgroth M, LaTempa TJ, Grimes CA, Desai TA. Titania nanotubes: a novel platform for drug-eluting coatings for medical implants. Small. 2007;3(11):1878-1881.
22. Losic D, Simovic S. Self-ordered nanopore and nanotube platforms for drug delivery applications. Expert Opin Drug Deliv. 2009;6(12):1363-1381.
23. Smith LJ, Swaim JS, Yao C, Haberstroh KM, Nauman EA, Webster TJ. Increased osteoblast cell density on nanostructured PLGA-coated nanostructured titanium for orthopedic applications. Int J Nanomedicine. 2007;2(3):493-499.
24. Aw MS, Simovic S, Addai-Mensah J, Losic D. Polymeric micelles in porous and nanotubular implants as a new system for extended delivery of poorly soluble drugs. J Mater Chem. 2011;21(20):7082-7089.
25. Aw MS, Gulati K, Losic D. Controlling drug release from titania nanotube arrays using polymer nanocarriers and biopolymer coating. J Biomater Nanobiotechnol. 2011;2:477-484.
26. Simovic S, Losic D, Vasilev K. Controlled drug release from porous materials by plasma polymer deposition. Chem Commun (Camb). 2010;46(8):1317-1319.
27. Gulati K, Ramakrishnan S, Aw MS, Atkins GJ, Findlay DM, Losic D. Biocompatible polymer coating of titania nanotube arrays for improved drug elution and osteoblast adhesion. Acta Biomater. 2012;8(1): 449-456.
28. Gulati K, Aw MS, Losic D. Drug-eluting Ti wires with titania nanotube arrays for bone fixation and reduced bone infection. Nanoscale Res Lett. 2011;6:571-577.
29. Vasilev K, Poh Z, Kant K, Chan J, Michelmore A, Losic D. Tailoring the surface functionalities of titania nanotube arrays. Biomater. 2010;31(3):532-540.
30. 2 nanotubes with through-hole morphology. Physica Status Solidi RRL. 2009;3(5): 139-141.
31. Aw MS, Addai-Mensah J, Losic D. Multi-drug delivery system with sequential release using titania nanotube arrays. Chem Commun (Camb). 2012;48(27):3348-3350.
32. Aw MS, Addai-Mensah J, Losic D. Magnetic-responsive delivery of drug carriers using titania nanotube arrays. J Mater Chem. 2012; 22(14):6561-6563.
33. Siepmann J, Lecomte F, Bodmeier R. Diffusion-controlled drug delivery systems: calculation of the required composition to achieve desired release profiles. J Control Release. 1999;60(2-3):379-389.
34. López T, Bata-García JL, Esquivel D, et al. Treatment of Parkinson's disease: nanostructured sol-gel silica-dopamine reservoirs for controlled drug release in the central nervous system. Int J Nanomedicine. 2010;6: 19-31.
35. D'Aurizio E, Sozio P, Cerasa LS, et al. Biodegradable microspheres loaded with an anti-Parkinson prodrug: an in vivo pharmacokinetic study. Mol Pharm. 2011;8(6):2408-2415.